Today the Court of Appeal handed down judgment in a highly significant case for the NHS which will have widespread effects, long after the present pandemic has finished. David Lock QC and David Blundell QC acted for the successful NHS bodies in R (Bayer and Novartis) v NHS Darlington Clinical Commissioning Groups and others.
In order to explain the background, arguments and consequences of this case, David Lock QC and David Blundell QC have prepared a series of papers and podcasts which are set out below:
Part 1: The Legal and Regulatory Background
Part 2: An explanation of the background to the treatment of wet AMD patients within the NHS
Part 3: Details of the policy adopted by the CCGs
Part 4: The grounds of challenge and the lines of defence
Part 5: The judgment of the Court of Appeal
Part 6: What happens next and the consequences for the NHS
A summary of the judgment and its effects may be found in the transcript of Part 5 above.
NHS bodies and solicitors who wish to seek advice concerning the implications for their local NHS of this highly significant ruling are invited to contact Ben Connor.